|1.||Zanetti, Margherita: 2 articles (04/2010 - 11/2006)|
|2.||Skerlavaj, Barbara: 2 articles (04/2010 - 11/2006)|
|3.||Pompilio, Arianna: 1 article (01/2012)|
|4.||Di Bonaventura, Giovanni: 1 article (01/2012)|
|5.||Scocchi, Marco: 1 article (01/2012)|
|6.||Mardirossian, Mario: 1 article (01/2012)|
|7.||Dicuonzo, Giordano: 1 article (01/2012)|
|8.||Fiscarelli, Ersilia: 1 article (01/2012)|
|9.||Crocetta, Valentina: 1 article (01/2012)|
|10.||Pomponio, Stefano: 1 article (01/2012)|
04/01/2010 - "The aims of this study were to investigate the expression of the bovine cathelicidins BMAP-27, BMAP-28, Bac5, and indolicidin in healthy and infected mammary tissue and in lipopolysaccharide (LPS)-treated cells, to determine their activities against bacteria isolated from bovine mastitis, and to examine their potentials to trigger defense responses in bovine mammary cells. "
|2.||Obstructive Jaundice (Cholestatic Jaundice)
11/01/2006 - "In light of its dual antimicrobial and anti-endotoxin properties, BMAP-27 could be an interesting compound to inhibit bacterial translocation and endotoxin release in obstructive jaundice."
11/01/2006 - "Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide."
|3.||Cystic Fibrosis (Mucoviscidosis)
01/01/2012 - "Three α-helical antimicrobial peptides, BMAP-27 and BMAP-28 of bovine origin, and the artificial P19(9/B) peptide were tested, comparatively to Tobramycin, for their in vitro antibacterial and anti-biofilm activity against 15 Staphylococcus aureus, 25 Pseudomonas aeruginosa, and 27 Stenotrophomonas maltophilia strains from cystic fibrosis patients. "